Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer
Advanced Science · 2024-06 · 11 (22)
DOI: 10.1002/advs.202310146 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 25.03.2024. Verfasst von Miner Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center f…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cisplatin, Histone Acetyltransferases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Bladder cancer (BC) is one of the most common tumors characterized by a high rate of relapse and a lack of targeted therapy. Here, YEATS domain‐containing protein 4 (YEATS4) is an essential gene for BC cell viability using CRISPR‐Cas9 library screening is reported, and that HUWE1 is an E3 ligase responsible for YEATS4 ubiquitination and proteasomal degradation by the Protein Stability Regulators Screening Assay. KAT8‐mediated acetylation of YEATS4 impaired its interaction with HUWE1 and consequently prevented its ubiquitination and degradation. The protein levels of YEATS4 and KAT8 are positively correlated and high levels of these two proteins are associated with poor overall survival in BC patients. Importantly, suppression of YEATS4 acetylation with the KAT8 inhibitor MG149 decreased YEATS4 acetylation, reduced cell viability, and sensitized BC cells to cisplatin treatment. The findings reveal a critical role of the KAT8/YEATS4 axis in both tumor growth and cisplatin sensitivity in BC cells, potentially generating a novel therapeutic strategy for BC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P.…
- Department of Hematology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, 510060, P. R. China.
- Center of Digestive Disease, Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107, P. R. China.
- School of Medicine, Shenzhen Campus of Sun Yat-Sen University, Shenzhen, 518107, P. R. China.
ORCID-Profile: Miner Xie, Yuanzhong Wu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Cancer Innovative Research Program of Sun Yat-sen University Cancer Center
Zitieren
APA
Xie, M., Zhou, L., Li, T., Lin, Y., Zhang, R., Zheng, X., Zeng, C., Zheng, L., Zhong, L., Huang, X., Zou, Y., Kang, T., & Wu, Y. (2024). Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer. Advanced Science, 11(22). https://doi.org/10.1002/advs.202310146
Vancouver
Xie M, Zhou L, Li T, Lin Y, Zhang R, Zheng X, et al. Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer. Advanced Science. 2024;11(22). doi:10.1002/advs.202310146
BibTeX
@article{Xie2024,
author = {Xie, Miner and Zhou, Liwen and Li, Ting and Lin, Yujie and Zhang, Ruhua and Zheng, Xianchong and Zeng, Cuiling and Zheng, Lisi and Zhong, Li and Huang, Xiaodan and Zou, Yezi and Kang, Tiebang and Wu, Yuanzhong},
title = {Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin Sensitivity in Bladder Cancer},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {22},
doi = {10.1002/advs.202310146}
}
EUVIMED